SCHEMBL30796907

SCHEMBL30796907

CC(C)(C)OC(=O)N1CCC(c2ccc(F)c(-c3cc(-c4ccccc4O)nnc3N)c2)CC1

nearest known ligand 0.61

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ SMARCA2 P51531 7/20 0.61
▸ SMARCA4 P51532 7/20 0.61
▸ PBRM1 Q86U86 7/20 0.61
▸ NAMPT P43490 1/20 0.44
▸ MAPT P10636 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ JAK2 O60674 3/20 0.42
▸ JAK3 P52333 3/20 0.42
▸ PTK2 Q05397 3/20 0.42
▸ TRPV3 Q8NET8 1/20 0.42
▸ GPR119 Q8TDV5 2/20 0.41
▸ DPP4 P27487 1/20 0.40
▸ HRH3 Q9Y5N1 2/20 0.40
▸ NR1I2 O75469 3/20 0.40
▸ NR1H2 P55055 1/20 0.40
▸ TP53 P04637 1/20 0.40
▸ THRB P10828 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27461726 1.00 SMARCA2 (0.61) SMARCA2SMARCA4PBRM1NAMPTMAPT
SCHEMBL31548738 0.87 SMARCA2 (0.65) SMARCA2SMARCA4PBRM1NAMPTJAK2
SCHEMBL27461434 0.85 SMARCA2 (0.62) SMARCA2SMARCA4PBRM1NAMPTJAK2
SCHEMBL30797067 0.85 SMARCA2 (0.62) SMARCA2SMARCA4PBRM1NAMPTJAK2
SCHEMBL30606905 0.84 SMARCA2 (0.71) SMARCA2SMARCA4PBRM1MAPTSMN1; SMN2
SCHEMBL20009090 0.84 SMARCA2 (0.71) SMARCA2SMARCA4PBRM1MAPTSMN1; SMN2
SCHEMBL18038859 0.81 PBRM1 (0.66) SMARCA2SMARCA4PBRM1NR1I2NR1H2
SCHEMBL30606896 0.81 PBRM1 (0.66) SMARCA2SMARCA4PBRM1NR1I2NR1H2
SCHEMBL24514506 0.79 PBRM1 (0.75) SMARCA2SMARCA4PBRM1GPR119NR1I2
SCHEMBL31548745 0.79 PBRM1 (0.57) SMARCA2SMARCA4PBRM1NAMPTJAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4539849-A1 COMPOUNDS FOR THE TARGETED DEGRADATION OF SMARCA2 C4 Therapeutics, Inc. (US) 2025-04-23 — — EP disclosed
WO-2023244764-A1 COMPOUNDS FOR THE TARGETED DEGRADATION OF SMARCA2 C4 THERAPEUTICS, INC. (US) 2023-12-21 — — WO disclosed
Send feedback